Top Markets
Coin of the day
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
株式のランク #31353
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
株価
$0.4018
時価総額
$14.12M
変化(1日)
-3.20%
変化(1年)
-88.15%
US
取引 Skye Bioscience, Inc. (SKYE)

カテゴリー

Skye Bioscience, Inc.(SKYE)の株価履歴
終値の最高値: $0.50 (2026-08-01)

終値の最安値: $2.50K (2014-11-01)
Skye Bioscience, Inc. の株価履歴(2014 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 27.56%
2025 -68.43%
2024 7.82%
2023 -19.28%
2022 -74.81%
2021 58.02%
2020 -81.19%
2019 -44.44%
2018 157.69%
2017 -64.63%
2016 -42.36%
2015 -92.76%
2014 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$532.21 36.51%
US
$1.00K 51.44%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE